Access cutting-edge nash treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access nash specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nash treatment provided free
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects.
Sponsor: Akero Therapeutics, Inc
Check if you qualify for this nash clinical trial in Birmingham, AL
If you're searching for nash treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nash specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.